AngioDynamics (ANGO) Comments On New Reimbursement Rate For Hospital-Based Varicose Vein Ablations
12/10/2013 9:22:09 AM
ALBANY, N.Y., Dec. 10, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the Centers for Medicare and Medicaid Services (CMS) has created a new Ambulatory Payment Classification (APC) that includes both in-hospital endovenous radiofrequency (RF) treatments and in-hospital endovenous laser varicose vein ablation, such as the Company's VenaCure EVLT procedure.
Help employers find you! Check out all the jobs and post your resume.
comments powered by